Did you know?

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Se... Here's a roundup of top develo...Cardiff Oncology's next trial in mCRC, ONSEMBLE, is designed to evaluate the safety and efficacy of onvansertib in combination with SoC FOLFIRI/bevacizumab in patients with second-line KRAS/NRAS ...Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. It is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted ...Track BlockCAT(CAT) Price, real-time chart movements, latest community messages, chart, news and related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTwo crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.Track CorMedix Inc (CRMD) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Snowflake Inc (SNOW) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors/PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug... CRDF : 4.07 (+2.01%) Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update PR Newswire - Wed Aug 9, 2023Ticker: CRDF CIK: 1213037 Form Type: 10-K Annual Report Accession Number: 0001628280-24-007948 Submitted to the SEC: Thu Feb 29 2024 4:00:21 PM EST Accepted by the SEC: Thu Feb 29 2024 Period: Sunday, December 31, 2023 Industry: Biological Products No Disgnostic Substances External Resources: Stock Quote Social …In clinical trials, Xofluza shortened the length of the flu if given within two days of symptoms starting. Last year the flu killed 80,000 individuals in the US. For the first time...CRDF | January 17, 2024. - Findings from the Phase 1b portion of company's Phase 1b/2 study in second-line KRAS-mutated mCRC highlight the safety and promising efficacy of onvansertib in combination with standard-of-care -. - These peer-reviewed published data are part of the Phase 1b/2 data Cardiff Oncology announced in August 2023 and ...Cardiff Oncology ( NASDAQ: CRDF) is a cancer-focused biotech working on developing a drug that exploits a novel target, particularly in colorectal cancer. In my past articles, I have been lukewarm ...Stock analysis for Cardiff Oncology Inc (CRDF:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Find the latest Cardiff Oncology, Inc. (CRDF) stock quote, history, news and other vital information to help you with your stock trading and investing. All debt owed by the company, including both long-term and short-term debt. This does not include accounts payable and similar liabilities, but may include leases depending on the analysis. $2.58M ...Track Crawford & Company (CRD) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsCardiff Oncology (CRDF) shares soared 20.5% in the last trading session to close at $5.40. The move was backed by solid volume with far more shares changing hands than in a normal session.The average one-year price target for Cardiff Oncology, Inc. is $10.71. The forecasts range from a low of $7.07 to a high of $14.7. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or ...CRDF Latest Real Time Trades. Select time range to see more trades: Last 100 Trades. NLS Time (ET) NLS Price. NLS Share Volume. 16:00:04. $ 2.50. 1,360.Track Amazon.com Inc (AMZN) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsDiscover historical prices for CRDF stock on Yahoo Finance. View daily, weekly or monthly format back to when Cardiff Oncology, Inc. stock was issued.Cardiff Oncology Inc. $4.07. After Hours: $4.17. (2.46%) +0.100. Closed: Apr 26, 5:20:00 PM GMT-4 · USD · NASDAQ · Disclaimer. 1D. 5D. 1M. 6M. YTD. 1Y. 5Y. MAX. search …Clinical-stage biotech Cardiff Oncology (CRDF) added ~14% in the pre-market trading Monday after the company announced Phase 1b/2 data for its lead asset Onvansertib in patients...Your neighbors are annoying you, yes. But guess what? You're probably annoying them, too. Living in a neighborhood can be a pleasant experience of convivial support, backyard barbe...

Track Cardio Diagnostics Holdings Inc (CDIO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Capricor Therapeutics Inc (CAPR) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsTrack Ideanomics Inc (IDEX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors2 days ago · 2 analysts have issued 1-year price targets for Cardiff Oncology's shares. Their CRDF share price targets range from $7.00 to $14.00. On average, they anticipate the company's share price to reach $10.50 in the next twelve months. This suggests a possible upside of 135.4% from the stock's current price. View analysts price targets for CRDF or ... Track Axonics Inc (AXNX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

CRDF is an oncology would-be pharma company currently supporting their ventures through one program: the polo-like kinase 1 (PLK1) inhibitor onvansertib. This enzyme controls DNA damage repair ...Track TRACON Pharmaceuticals Inc (TCON) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsLiquidity, cash burn, and cash runway. As of December 31, 2023, Cardiff Oncology had approximately $75 million in cash, cash equivalents, and short-term investments. Net cash used in operating ...…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Adam McCann, WalletHub Financial WriterMar 27, 2023 Adam Mc. Possible cause: 52 Week Low Date 11/10/23. Market Cap 196.279M. Shares Out 44.71M. 10 Day .